In a complementary study, antitumor CD8 T cell responses in young (prepubescent) versus adult (presenescent) mice demonstrate that young tumor-reactive CD8 T cells can become terminally differentiated, exhibiting overexpression of inhibitory receptors and the transcription factor Tox1 [47]. The gene discussed is CD8A; the disease is neoplasm.